Skip to content

Insider · CIK 0001258360

Robert Andrew Berman

ceoofficerdirector

Files at NVNO (enVVeno Medical Corp). First filing Dec 19, 2024, latest Dec 19, 2024.

In brief

Robert Andrew Berman files SEC Form 4 as CEO and director at NVNO (enVVeno Medical Corp). Since Dec 19, 2024, Robert Andrew Berman has reported 1 open-market buy worth $31k and 0 open-market sells worth $0, the latest filed on Dec 19, 2024.

A track record needs three past buys with six months of prices behind them; Robert Andrew Berman has 0, so none is measured yet.

The newest scored trade: bought $31k of NVNO on Dec 19, 2024, filed Dec 19, 2024, scored 48 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$31k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NVNO: enVVeno Medical Corp

NVNOOct 9, 2026 · close 8.75

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
48Moderate
NVNObuy 5
enVVeno Medical Corp
$31k
12,000 shares
+6%-

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 16, 2025NVNO
enVVeno Medical Corp
JOther
Restricted Stock Unitsderivative
-200,000$0.00$00Dec 18, 2025
Dec 18, 2024NVNO
enVVeno Medical Corp
AGrant or award
Stock Optionsderivative
+200,000$0.00$0200,000Dec 20, 2024
Dec 19, 2024NVNO
enVVeno Medical Corp
POpen-market purchase
Common Stock
+12,000$2.55$31k222,236Dec 19, 2024

Questions about Robert Andrew Berman

Answered from the filings on this page, as of the latest one.

Is Robert Andrew Berman buying or selling?

Not in the last 12 months. Robert Andrew Berman's latest open-market trade on SEC Form 4 was bought $31k of NVNO on Dec 19, 2024.

How did Robert Andrew Berman's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Andrew Berman has 0.

Where does Robert Andrew Berman file Form 4?

Robert Andrew Berman has filed Form 4 at NVNO (enVVeno Medical Corp) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert Andrew Berman: insider trades and track record | InsiderTell